Isolated Ebola Cases Hard to Diagnose, Go Undetected

Wide availability of infection control and diagnostic resources is required to control outbreaks early.

Written byMunyaradzi Makoni
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, ZMEEL

Half of isolated Ebola cases have gone undetected since the disease was first discovered in 1976, according to an analysis of outbreaks by scientists published last week (June 13) in PLOS Neglected Tropical Diseases.

The virus circulates in wildlife all the time, and the rate of such spillover is intimately linked with its public health consequences. But it’s unclear how often it happens. By modelling patterns of Ebola outbreaks, the team estimated that many spillover events are overlooked entirely.

“We estimate that outbreaks are unlikely to be detected within their first few cases, and this has important public health consequences,” says lead author Emma Glennon, a disease ecologist at the University of Cambridge.

People with undocumented cases of Ebola most likely die of the disease as they don’t receive care at health facilities, says Yap Boum, regional representative of the Uganda-based Epicenter Africa, the research arm ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • munya makoni

    Munyaradzi is a freelance journalist based in Cape Town, South Africa. He covers agriculture, climate change, environment, health, higher education, sustainable development, and science in general. Among other outlets, his work has appeared in Hakai magazine, Nature, Physics World, Science, SciDev.net, The Lancet, The Scientist, Thomson Reuters Foundation, and University World News.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies